XML 315 R276.htm IDEA: XBRL DOCUMENT v3.20.4
Note 47 - Impairment or reversal of impairment on financial assets not measured at fair value through profit or loss (Details) - EUR (€)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
 [1]
Dec. 31, 2018
 [1]
Impairment or reversal of impairment on financial assets not measured at fair value through profir or loss      
Financial assets measured at cost, debt securities, impairment or reversal of impairment € 19,000,000 € 82,000,000 € 1,000,000
Loans and receivables, impairment or reversal of impairment 5,160,000,000 3,470,000,000 3,680,000,000
Recovery of written-off assets (339,000,000) (919,000,000) (589,000,000)
Total impairment or reversal of impairment on financial assets not measured at fair value through profit or loss € 5,179,000,000 € 3,552,000,000 [2] € 3,681,000,000 [2]
[1]

(*) In 2020, the amount includes the negative impact of the update of the macroeconomic scenario following the COVID-19 pandemic (see Notes 1.5 and 7.2).

[2]

(*) Restated due to the sale of the stake in BBVA USA (see Notes 3 and 21).